ABILENE, TX –– Hendrick Health announced it has temporarily suspended treatments at the Covid Infusion Clinic as they await further direction from state officials.
The latest research indicates Sotrovimab is the only effective monoclonal antibody to combat the omicron variant. Other antibody treatments have proven to be ineffective and even potentially cause more harm than good.
The supply of Sotrovimab is currently limited, but additional units have been ordered from the state. A shortage of monoclonal antibody infusion treatment has been affecting the entire state.
According to officials, the hospital is waiting for further information from the state and CDC to determine what steps are next.
Hendrick Health continues to urge all eligible members of the public to ger all l recommended doses of the COVID-19 vaccine, social distance, and wear a mask.
Subscribe to the LIVE! Daily
Required
Post a comment to this article here: